| Nucleic acids-based therapeutics in the battle against pathogenic viruses. | |
| | |
MedLine Citation:
|
PMID: 19048203 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
For almost three decades, researchers have studied the possibility to use nucleic acids as antiviral therapeutics. In theory, compounds such as antisense oligonucleotides, ribozymes, DNAzymes, and aptamers can be designed to trigger the sequence-specific inhibition of particular mRNA transcripts, including viral genomes. However, difficulties with their efficiency, off-target effects, toxicity, delivery, and stability halted the development of nucleic acid-based therapeutics that can be used in the clinic. So far, only a single antisense drug, Vitravene for the treatment of CMV-induced retinitis in AIDS patients, has made it to the clinic. Since the discovery of RNA interference (RNAi), there is a renewed interest in the development of nucleic acid-based therapeutics. Antiviral RNAi approaches are highly effective in vitro and in animal models and are currently being tested in clinical trials. Here we give an overview of antiviral nucleic acid-based therapeutics. We focus on antisense and RNAi-based compounds that have been shown to be effective in animal model systems. |
| | |
Authors:
|
Joost Haasnoot; Ben Berkhout |
Related Documents
:
|
19250833 - Fluorescence emission properties of 8-aza analogues of caffeine, theophylline, and rela... 15217103 - Submerged cultivation of medicinal mushrooms for production of valuable bioactive metab... 2865983 - Gamma-glutamyl-amino acids as signals for the hormonal regulation of amino acid uptake ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Handbook of experimental pharmacology Volume: - ISSN: 0171-2004 ISO Abbreviation: Handb Exp Pharmacol Publication Date: 2009 |
Date Detail:
|
Created Date: 2008-12-02 Completed Date: 2009-03-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7902231 Medline TA: Handb Exp Pharmacol Country: Germany |
Other Details:
|
Languages: eng Pagination: 243-63 Citation Subset: IM |
Affiliation:
|
Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam K3-110, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antiviral Agents / adverse effects, pharmacology*, therapeutic use* Aptamers, Nucleotide / adverse effects, therapeutic use Humans Nucleic Acids / adverse effects, pharmacology*, therapeutic use* Oligonucleotides, Antisense / adverse effects, pharmacology, therapeutic use RNA Interference / drug effects RNA, Catalytic / adverse effects, therapeutic use RNA, Small Interfering / adverse effects, therapeutic use Virus Diseases / drug therapy* Viruses / drug effects* |
| Chemical | |
Reg. No./Substance:
|
0/Antiviral Agents; 0/Aptamers, Nucleotide; 0/Nucleic Acids; 0/Oligonucleotides, Antisense; 0/RNA, Catalytic; 0/RNA, Small Interfering |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Interferons and their use in persistent viral infections.
Next Document: Antiviral gene therapy.